BioCentury
ARTICLE | Financial News

Shanghai Cell Therapy raises $134M series C

January 4, 2019 3:53 AM UTC

Shanghai Cell Therapy Group Co. Ltd. (Shanghai, China) raised RMB925 million ($134.1 million) on Dec. 18 in a series C round that the company said will support development of its cell therapies, innovative cell techniques and cancer hospital featuring precision cell therapy.

The financing was led by China Pacific Insurance, Haier Capital and China Industrial Asset Management, with participation by Legend Capital, Anting Industrial, Ningbo Yuanhui and others...